Metraipolis › archive › dc_cba6cbdc8b47

Developing a theranostic nanobody targeting FAP for cancer imaging and therapy — Europe PMC PMID:41460404

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41460404
DOI
10.1186/s41181-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T08:42:44.322Z
SHA-256 of the archived text
2c80672288d7b586e0ad0548b94edf937f9fff3aa862bf945d5314b296c30b6d
Stable URL of this page
https://metraipolis.com/documento/dc_cba6cbdc8b47

How to cite

Developing a theranostic nanobody targeting FAP for cancer imaging and therapy — Europe PMC PMID:41460404 — Europe PMC (en), https://europepmc.org/article/MED/41460404 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cba6cbdc8b47 (Metraipolis archive dc_cba6cbdc8b47, sha256 2c80672288d7b586e0ad0548b94edf937f9fff3aa862bf945d5314b296c30b6d)
BibTeX
@misc{dccba6cbdc8b47,
  title = {Developing a theranostic nanobody targeting FAP for cancer imaging and therapy — Europe PMC PMID:41460404},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41460404},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cba6cbdc8b47; sha256 2c80672288d7b586e0ad0548b94edf937f9fff3aa862bf945d5314b296c30b6d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41460404. Agents can read the archived copy with the MCP tool read_document.